Lymphoma (mantle cell) - bendamustine (1st line, with rituximab) [ID609]

  • Discontinued
  • GID-TAG321

Documents

Documents created during the development process.

Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): equality impact assessment

Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): response to consultee and commentator comments on the draft scope

Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): final matrix

Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): final scope

Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): draft scope consultation (post referral) - October 2012

Lymphoma (mantle cell) - bendamustine (1st line, with rituximab): provisional matrix (post referral) - October 2012